Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES)

Posterior reversible encephalopathy syndrome (PRES), first introduced in 1996, is a neurotoxic state characterised by seizures, headache, vision change, paresis, nausea and altered mental status. Risk factors include hypertension, eclampsia/pre-eclampsia, infection/sepsis and cancer chemotherapy. Al...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMJ Case Rep
Hlavní autoři: Janjua, Taimoor Khalid, Hassan, Muhammad, Afridi, Hira Khan, Zahid, Naila Anjum
Médium: Artigo
Jazyk:Inglês
Vydáno: BMJ Publishing Group 2017
Témata:
Unusual Association of Diseases/Symptoms
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5652359/
https://ncbi.nlm.nih.gov/pubmed/28978604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2017-221571
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky